Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With Iron Deficiency Anemia

Trial Profile

Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With Iron Deficiency Anemia

Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Iron isomaltoside 1000 (Primary) ; Iron isomaltoside 1000 (Primary)
  • Indications Iron deficiency anaemia; Metabolic disorders
  • Focus Adverse reactions
  • Sponsors Pharmacosmos
  • Most Recent Events

    • 02 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 09 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top